Hissong, E., Jafari, M. D., Khan, S., Kasi, P. M., Guniganti, P., Ocean, A. J., Siolas, D., Yeo, H., Khan, U., Pigazzi, A., Lutfi, A., Chen, Z., Shah, M. A., Hidalgo, M. (2025). Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient (pMMR) and deficient (dMMR) colorectal cancer (CRC): NEST clinical trial update.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.207